  Background: Information on influenza-associated mortality in Russia is
limited.
  Methods: Using previously developed methodology (Goldstein et al.,
Epidemiology 2012), we regressed the monthly rates of mortality for respiratory
causes, as well as circulatory causes linearly against the monthly proxies for
the incidence of influenza A/H3N2, A/H1N1 and B (obtained using data from the
Smorodintsev Research Institute of Influenza (RII)), adjusting for the baseline
rates of mortality not associated with influenza circulation and temporal
trends.
  Results: For the 2013/14 through the 2018/19 seasons, influenza circulation
was associated with an average annual 17636 (95% CI (9482,25790)) deaths for
circulatory causes and 4179 (3250,5109) deaths for respiratory causes, with the
largest number of deaths (32298 (18071,46525) for circulatory causes and 6689
(5019,8359) for respiratory causes) estimated during the 2014/15 influenza
season. The biggest contributor to both circulatory and respiratory
influenza-associated deaths was influenza A/H3N2, followed by influenza B and
A/H1N1. Compared to the 2013/14 through the 2015/16 seasons, during the 2016/17
through the 2018/19 seasons (when levels of influenza vaccination were
significantly higher), the volume of influenza-associated mortality declined by
about 16.1%, or 3809 annual respiratory and circulatory deaths.
  Conclusions: Influenza circulation is associated with a substantial mortality
burden in Russia, particularly for circulatory deaths, with some reduction
observed following the major increase in vaccination coverage. Those results
support the potential utility of further extending the levels of influenza
vaccination, the use of quadrivalent influenza vaccines, and extra efforts for
protecting individuals with circulatory disease in Russia, including
vaccination and the use of antiviral medications.
